ArticleInternational journal of technology assessment in health care2022
Designing and Implementing Deliberative Processes for Health Technology Assessment: A Good Practices Report of a Joint HTAi/ISPOR Task Force.
Article in International journal of technology assessment in health care, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Using best-worst scaling to inform policy decisions in Africa: a literature review.BMC public health · 2024Pooled it
- Advancing health technology assessment in Taiwan: over 15 years of evidence-based reform, innovation, and patient partnership.International journal of technology assessment in health care · 2026Review
- Competencies for health technology assessment professionals: a scoping review and content analysis.International journal of technology assessment in health care · 2026Article
- Improving Collaborative Engagement in Health State Valuation: A Scoping Review of Current Practices and Emerging Recommendations.PharmacoEconomics · 2026Review
- Strengthening health technology assessment in Greece: industry-identified barriers and recommendations.Frontiers in public health · 2026Article
- A Mixed-Methods Assessment of India's Health Technology Assessment Ecosystem.Applied health economics and health policy · 2026Article
- Institutionalization of Health Technology Assessment of medical devices: a cluster analysis of EU, EEA, and EFTA countries.International journal of technology assessment in health care · 2025Article
- Towards institutionalizing HTA in Ethiopia: using a political economy analysis to explore stakeholder perspectives and assessing capacity needs.International journal of technology assessment in health care · 2025Article
- Health technology assessment capacity to support Zambia's health benefits package reform policy.International journal of technology assessment in health care · 2025Article
- CMS's Drug Price Negotiation Program 2023 Patient-Focused Listening Sessions: A Descriptive Analysis of Speaker Remarks.PharmacoEconomics - open · 2025Article
- Development of the PICCOTEAM Reference Case for Economic Evaluation of Precision Medicine.International journal of health policy and management · 2025Article
- Incorporating healthcare access and equity in economic evaluations: a scoping review of guidelines.International journal of technology assessment in health care · 2024Article
- Advancing evidence-based decision-making in Bhutan: development of a health technology assessment framework.The Lancet regional health. Southeast Asia · 2024Review
- Assessing medical devices: a qualitative study from the validate perspective.International journal of technology assessment in health care · 2024Article
- The Full Value of Vaccine Assessments Concept-Current Opportunities and Recommendations.Vaccines · 2024Article
- Application of Multi-Criteria Decision Analysis (MCDA) to Prioritize Real-World Evidence Studies for Health Technology Management: Outcomes and Lessons Learned by the Canadian Real-World Evidence for Value of Cancer Drugs (CanREValue) Collaboration.Current oncology (Toronto, Ont.) · 2024Article
- Moving Towards Effective and Efficient Implementation of Evidence-Informed Deliberative Processes for Health Benefit Package Design: A Response to Recent Commentaries.International journal of health policy and management · 2024Article
- Future Role of Health Technology Assessment for Genomic Medicine in Oncology: A Canadian Laboratory Perspective.Current oncology (Toronto, Ont.) · 2023Review
- Translating Precision Health for Pediatrics: A Scoping Review.Children (Basel, Switzerland) · 2023Article
- Civil society and medical product access in Africa: Lessons from COVID-19.Frontiers in medical technology · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
Abstract
objectivesDeliberative processes for health technology assessment (HTA) are intended to facilitate participatory decision making, using discussion and open dialogue between stakeholders. Increasing attention is being given to deliberative processes, but guidance is lacking for those who wish to design or use them. Health Technology Assessment International (HTAi) and ISPOR-The Professional Society for Health Economics and Outcomes Research initiated a joint Task Force to address this gap.
methodsThe joint Task Force consisted of fifteen members with different backgrounds, perspectives, and expertise relevant to the field. It developed guidance and a checklist for deliberative processes for HTA. The guidance builds upon the few, existing initiatives in the field, as well as input from the HTA community following an established consultation plan. In addition, the guidance was subject to two rounds of peer review.
resultsA deliberative process for HTA consists of procedures, activities, and events that support the informed and critical examination of an issue and the weighing of arguments and evidence to guide a subsequent decision. Guidance and an accompanying checklist are provided for (i) developing the governance and structure of an HTA program and (ii) informing how the various stages of an HTA process might be managed using deliberation.
conclusionsThe guidance and the checklist contain a series of questions, grouped by six phases of a model deliberative process. They are offered as practical tools for those wishing to establish or improve deliberative processes for HTA that are fit for local contexts. The tools can also be used for independent scrutiny of deliberative processes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.